Last additions - Macular Degeneration - Age Related, Myopic, Choroidal Neovascular Membranes
|
Myopic CNVM Left Eye82 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye90 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye91 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye89 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye87 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye96 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye107 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion84 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion82 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion78 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion73 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion71 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion86 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion86 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion82 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion94 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion67 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion78 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion92 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion92 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion74 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion82 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion84 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion71 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion90 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion80 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion82 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion69 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion93 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion71 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion83 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye139 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye90 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye81 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye73 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye64 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye79 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye70 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye68 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye96 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye73 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye87 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye87 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye80 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye98 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye110 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye83 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye71 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye68 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye79 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye75 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye83 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye94 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye92 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye90 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye103 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye91 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye82 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye94 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
Large Hyper-reflective drusen in age-related macular degeneration190 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration195 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration175 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration168 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration194 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration181 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration179 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration158 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration186 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Non exudative MNV145 viewsSep 18, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion180 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion179 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion162 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion148 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion148 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion180 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion182 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion175 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion196 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years168 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years169 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years155 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years152 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years166 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years169 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years163 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years159 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years153 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years140 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years163 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years158 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years167 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years152 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years141 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years127 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years178 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years171 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years141 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years160 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years173 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years180 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
| 2694 files on 27 page(s) |
 |
3 | |
|
|
|
|
|
|
|
|
